News
Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...
A delay, as opposed to a firm stagnation, then, but one unfolding over several years. This applies not only to SMEs, but to big pharma, too, in terms of restructuring and refocusing – even in terms of ...
7h
The Business & Financial Times on MSNAdopt treatment of SCD under Mahama Care InitiativeAdopt treatment of SCD under Mahama Care InitiativeThe Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has called on President John Dramani Mahama to include full coverage of sickle cell disease treatment under ...
Beam Therapeutics Inc. (NASDAQ:BEAM) ranks among the best CRISPR stocks to buy. On June 13, Beam Therapeutics Inc.
Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...
What was supposed to be a five-year, $750,000 NIH grant to fund Dr. Charity Oyedeji's sickle cell research at Duke University – was terminated.
Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding ...
Dr. Elizabeth Disbrow, the director for the Center for Brain Health at LSU Health Shreveport, joined KSLA on June 26 to ...
A researcher at Duke University, speaks out after her NIH grant for sickle cell research was terminated. The $750,000 funding cut, justified by NIH as a move against diversity, equity, and inclusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results